When did MRNA join the S&P 500?

Moderna joined the S&P 500 index on 2021-07-21.

What sector is MRNA in?

MRNA is in the Health Care sector, Biotechnology industry.

MRNA — Moderna

Name: MRNA Institutional Holdings (13F) — 2026Q1
Creator: SEC EDGAR
License: https://www.sec.gov/data

Biotechnology · Health Care

Moderna is a commercial-stage biotechnology company founded in 2010 and went public in December 2018. The company's mRNA technology was validated through its COVID-19 vaccine, which received U.S. approval in December 2020. As of August 2025, Moderna has 35 mRNA development candidates in clinical studies spanning a broad range of therapeutic areas, including infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases.

Key Facts

Status	Active
Sector	Health Care
Industry	Biotechnology
Joined	2021-07-21
Tenure	4 yrs

S&P 500 Timeline

2021-07-21Joined S&P 500

Industry Peers

ABBV AMGN BIIB GILD INCY REGN VRTX

Sector Peers

A ABBV ABT ALGN AMGN BAX BDX BIIB BMY BSX

Institutional Holdings (13F)

726 institutions hold MRNA, totaling 378.3M shares ($19.2B) · As of 2026Q1

Rank	Institution	Shares	Value
1	VANGUARD CAPITAL MANAGEMENT LLC	45.7M	$2.3B
2	FMR LLC	45.7M	$2.3B
3	BlackRock, Inc.	29.6M	$1.5B
4	BARCLAYS PLC	16.3M	$1.4B
5	BAILLIE GIFFORD & CO	20.0M	$1.0B
6	Capital World Investors	18.7M	$950M
7	MORGAN STANLEY	27.3M	$949M
8	VANGUARD PORTFOLIO MANAGEMENT LLC	15.6M	$793M
9	STATE STREET CORP	14.9M	$755M
10	GEODE CAPITAL MANAGEMENT, LLC	9.4M	$478M

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10